Patients on blood pressure medication experience lower mortality at 30 days, according to research from Toronto General Hospital reported in Anesthesiology News.
The Latest
Insurance company Aetna has received permission from Connecticut regulators to reduce premiums on individual polices by an average of 10 percent, starting Sept. 2011, according to an LA Times report.
Health Alliance Medical Plans recently asked a judge for a temporary restraining order to block Illinois' new state health insurance contracts and continue Health Alliance HMO as an option for state employees, retirees and dependents, according to a MySurburbanLife report.
The price of health insurance premiums for Connecticut workers and their families has risen 102 percent since 1999, according to an analysis by the Connecticut Health Investigative Team, reported in The Day.
Four patient safety bills, aimed at increasing transparency at hospitals, are awaiting action, according to a Las Vegas Sun news report.
A motion for dismissal has been denied by a U.S. district court judge, allowing a whistleblower case accusing Daytona Beach, Fla.-based Halifax Health Medical Center of Medicare fraud and kickbacks to continue, according to a Daytona Beach News-Journal report. Halifax’s…
A survey of hospital faculty and residents showed that although they recognize the need to appropriately prescribe medication in order to prevent resistance to antibiotics, they were more likely to blame inappropriate administration to others and not themselves, according to…
The California Occupational Safety and Health Administration has granted University of California – San Diego and nine other UC system campuses an exception from using potent greenhouse gases to safety-test lab fume hoods, due to the toxic effect of the…
Researchers have recently suggested peripheral venous catheter-related Staphylococcus aureus bacteremia is an oft-overlooked complication in healthcare settings, according to a study published in Infection Control and Hospital Epidemiology.
A judge in South Carolina has ruled that Janssen Pharmaceutica — a subsidiary of Johnson & Johnson — must pay the state $327 million for deceptive drug marketing, according to a Wall Street Journal report. A jury concluded earlier this…